Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Update

by · The Markets Daily

Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Free Report) was the target of a significant growth in short interest in the month of June. As of June 30th, there was short interest totaling 114,234 shares, a growth of 1,418.5% from the June 15th total of 7,523 shares. Currently, 7.6% of the company’s stock are sold short. Based on an average daily volume of 53,894 shares, the days-to-cover ratio is presently 2.1 days.

Institutional Trading of Global X Genomics & Biotechnology ETF

Hedge funds and other institutional investors have recently modified their holdings of the business. IFP Advisors Inc lifted its stake in shares of Global X Genomics & Biotechnology ETF by 20.8% in the third quarter. IFP Advisors Inc now owns 2,835 shares of the company’s stock worth $110,000 after acquiring an additional 489 shares in the last quarter. Smartleaf Asset Management LLC grew its stake in Global X Genomics & Biotechnology ETF by 30.9% during the 2nd quarter. Smartleaf Asset Management LLC now owns 19,548 shares of the company’s stock valued at $164,000 after purchasing an additional 4,615 shares in the last quarter. Sei Investments Co. grew its stake in Global X Genomics & Biotechnology ETF by 110.4% during the 2nd quarter. Sei Investments Co. now owns 23,073 shares of the company’s stock valued at $194,000 after purchasing an additional 12,105 shares in the last quarter. Wealth Management Partners LLC purchased a new stake in Global X Genomics & Biotechnology ETF during the 1st quarter worth approximately $244,000. Finally, Creative Financial Designs Inc. ADV increased its holdings in Global X Genomics & Biotechnology ETF by 4.1% during the 4th quarter. Creative Financial Designs Inc. ADV now owns 12,124 shares of the company’s stock worth $551,000 after purchasing an additional 481 shares during the last quarter. 56.95% of the stock is owned by hedge funds and other institutional investors.

Global X Genomics & Biotechnology ETF Price Performance

GNOM traded down $1.89 during trading hours on Friday, reaching $56.65. 33,529 shares of the stock traded hands, compared to its average volume of 14,357. Global X Genomics & Biotechnology ETF has a fifty-two week low of $34.04 and a fifty-two week high of $59.48. The company has a market cap of $85.54 million, a price-to-earnings ratio of -24.21 and a beta of 1.16. The firm’s fifty day simple moving average is $50.36 and its two-hundred day simple moving average is $47.61.

Global X Genomics & Biotechnology ETF Announces Dividend

The company also recently disclosed a dividend, which was paid on Tuesday, July 7th. Shareholders of record on Monday, June 29th were given a $0.0579 dividend. The ex-dividend date of this dividend was Monday, June 29th. Global X Genomics & Biotechnology ETF’s dividend payout ratio is presently -27.35%.

Global X Genomics & Biotechnology ETF Company Profile

(Get Free Report)

Complete Genomics, Inc is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center.

Featured Articles